GlassScriptPhysician profile
Allie M Sohn
NPI 1245527191
$2,024.96
in general payments reported to CMS, 2019-2025
34 companies · $48.71 in 2025
The $48.71 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2020: $635 · 2021: $201 · 2022: $336 · 2023: $302 · 2024: $172 · 2025: $48.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $523.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $523.67 | 2020 | |
| Silk Road Medical, INC. | $406.79 | 2019-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Bard Peripheral Vascular, INC. | $203.58 | 2021-2024 | Venovo |
| Boston Scientific Corporation | $74.82 | 2022-2023 | Rotapro |
| Novartis Pharmaceuticals Corporation | $69.83 | 2021-2023 | |
| Amgen INC. | $67.10 | 2019-2022 | |
| Endologix LLC | $52.41 | 2019 | |
| Lemaitre Vascular, INC. | $50.42 | 2019-2023 | Artegraft Vascular Graft |
| Integra Lifesciences Corporation | $41.74 | 2022 | |
| Terumo Medical Corporation | $35.55 | 2019-2021 | |
| Nevro Corp. | $34.82 | 2022 | |
| Kerecis Limited | $33.35 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Organogenesis INC. | $32.17 | 2021-2023 | Puraply |
| Actelion Pharmaceuticals US, INC. | $31.85 | 2022-2023 | Opsumit, Uptravi |
| Janssen Pharmaceuticals, INC | $30.77 | 2022-2023 | Xarelto |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $30.36 | 2021 | |
| Scpharmaceuticals INC. | $28.76 | 2024-2025 | |
| Shockwave Medical, INC | $21.38 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $20.83 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.44 | 2019 | |
| Teleflex LLC | $19.42 | 2021 | |
| W. L. Gore & Associates, INC. | $18.59 | 2025 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Inari Medical, INC. | $18.03 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Acelrx Pharmaceuticals, INC. | $16.04 | 2022 | |
| Lundbeck LLC | $15.85 | 2019 | |
| Conetic Solutions, INC. | $15.74 | 2023 | |
| Sanofi-Aventis U.S. LLC | $15.10 | 2019 | |
| Merck Sharp & Dohme LLC | $14.47 | 2023 | Verquvo |
| Cook Medical LLC | $14.40 | 2019 | |
| Cvrx, INC. | $14.18 | 2024 | Barostim Neo System |
| Regeneron Healthcare Solutions, INC. | $14.17 | 2019 | |
| Pfizer INC. | $13.33 | 2024 | |
| Chiesi USA, INC. | $13.20 | 2021 | |
| Penumbra, INC. | $12.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allie Sohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.